Skip to content

Extracorporeal shockwave therapy versus B-ultrasound-guided combined nerve block with combined sacroiliac articular and internal interface for sacroiliac joint pain after lumbar fusion: a prospective, multicenter, randomized controlled study

Extracorporeal shockwave therapy versus B-ultrasound-guided combined nerve block with combined sacroiliac articular and internal interface for sacroiliac joint pain after lumbar fusion: a prospective, multicenter, randomized controlled study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098821
Enrollment
Unknown
Registered
2025-03-13
Start date
2024-03-11
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sacroiliac joint pain

Interventions

Extracorporeal shock wave group:15mm diameter probe, impact measurement 2000 times, frequency 5Hz, energy 0.1mJ/mm2, 1 time every 3 days, a total of 4 times
B-ultrasound-guided sacroiliac joint and internal nerve block group:Under the guidance of B-ultrasound, 0.5ml of compound betamethasone 2% lidocaine 5ml was punctured into the sacroiliac joint space w

Sponsors

The First Hospital of Jiaxing
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with sacroiliac joint pain after surgery due to lumbar degenerative changes and lumbar fusion internal fixation; 2. Sacroiliac joint pain symptoms lasting more than 6 months; 3. At least 3 positive sacroiliac joint inducibility tests (Patrick's test, Gaenslen's test, pelvic crush test, traction test and thigh thrust test); 4. Sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with severe heart, liver, kidney, brain and other diseases; 2. Those who are unable to cooperate with the completion of shock wave or sacroiliac joint nerve block during the operation; 3. Pregnant patients; 4. Those with buttock pain caused by ankylosing spondylitis, tumors, fractures, tuberculosis, etc.

Design outcomes

Primary

MeasureTime frame
Visual analogue scale score;Oswestry disability index;Patient Health Questionnaire;European Five-Dimensional Health Scale score;Treatment failure (re-injection, re-ESWT or fusionsurgery);

Secondary

MeasureTime frame
Complications;

Countries

China

Contacts

Public ContactZhenqi Lou

Department of Orthopedic Surgery, The First Hospital of Jiaxing

18815283514@163.com+86 188 1528 3514

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026